Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Diabetologia
Erschienen in: Diabetologia 6/2006

01.06.2006 | Article

The equivocal metabolic response to endotoxaemia in type 2 diabetic and obese ZDF rats

verfasst von: L. Belabed, G. Senon, M.-C. Blanc, A. Paillard, L. Cynober, S. Darquy

Erschienen in: Diabetologia | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The metabolic and endocrine disturbances associated with obesity and type 2 diabetes may impair the normal metabolic response to injury. Our objective was to investigate amino acid metabolism in endotoxaemic type 2 diabetic obese rats.

Materials and methods

A metabolic study was performed over 4 days using male Zucker diabetic fatty (ZDF) rats (fa/fa) and lean littermates (fa/+) divided into three groups: ad libitum-fed groups which underwent no treatment, lipopolysaccharide (LPS)-treated groups receiving E. coli LPS by i.p. injection, and pair-fed groups to the respective LPS groups. We evaluated the effect of endotoxaemia on body weight, food intake and tissue weights. Nitrogen loss and muscular proteolysis were measured daily by determination of urinary 3-methylhistidine (3-MH) excretion. Plasma, intestine and muscle amino acid levels were measured.

Results

The data showed that ad libitum-fed ZDF rats had lower plasma arginine and glutamine levels than ad libitum-fed control rats. Compared with control rats, the LPS-treated ZDF rats presented lower thymic involution, a lower 3-MH:creatinine ratio and higher cumulative nitrogen balance.

Conclusions/interpretation

Against our working hypothesis, ZDF rats did not show an impaired metabolic response, and even appeared to be less sensitive to the stress.
Literatur
1.
2.
Dhatariya K, Sreekumaran Nair K (2004) Diabetes mellitus. In: Cynober L (ed.) Metabolic and therapeutics aspects of amino acids in clinical nutrition. CRC, Boca Raton, Florida, pp 355–373
3.
4.
Biolo G, Toigo G, Ciocchi B et al (1997) Metabolic response to injury and sepsis: changes in protein metabolism. Nutrition 13:52S–57SPubMedCrossRef
5.
Van Den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef
6.
Chiolero RL, Tappy L, Berger MM (2003) Nutritional support of obese critically ill patients. Nestle Nutrition Workshop Series. Clinical and Performance Programme 187–200
7.
De Bandt JP (2004) Insulin and the regulation of amino acid catabolism and protein turnover. In: Cynober L (ed.) Metabolic and therapeutics aspects of amino acids in clinical nutrition. CRC, Boca Raton, Florida, pp 355–373
8.
Peterson RG, Shaw WN, Neel M-A et al (1990) Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News 32:16–19
9.
Unger RH (1997) How obesity causes diabetes in Zucker diabetic fatty rats. Trends Endocrinol Metab 8:276–282PubMedCrossRef
10.
Pernet P, Coudray-Lucas C, Schneid C, Jardel A, Cynober L (2004) Dose dependency of the effect of ornithine alpha-ketoglutarate on tissue glutamine concentrations and hypercatabolic response in endotoxaemic rats. Br J Nutr 92:627–634PubMedCrossRef
11.
Loi C, Osowska S, Neveux N, Darquy S, Cynober L, Moinard C (2005) Effects of an immune-enhancing diet in endotoxemic rats. Nutrition 21:255–263PubMedCrossRef
12.
Schlegel L, Coudray-Lucas C, Barbut F, Le Boucher J, Pernet P, Cynober L (1999) Bacterial dissemination, rather than translocation, mediates hypermetabolic response in endotoxemic rats. Crit Care Med 27:1511–1516PubMedCrossRef
13.
Wijekoon EP, Skinner C, Brosnan ME, Brosnan JT (2004) Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can J Physiol Pharmacol 82:506–514PubMedCrossRef
14.
Young VR, Munro HN (1978) Ntau-methylhistidine (3-methylhistidine) and muscle protein turnover: an overview. Fed Proc 37:2291–2300PubMed
15.
Blanc MC, Neveux N, Laromiguiere M, Berard MP, Cynober L (2000) Evaluation of a newly available biochemical analyzer: the Olympus AU 600. Clin Chem Lab Med 38:465–475PubMedCrossRef
16.
Grimble GK, West MF, Acuti AB et al (1988) Assessment of an automated chemiluminescence nitrogen analyzer for routine use in clinical nutrition. JPEN J Parenter Enteral Nutr 12:100–106PubMedCrossRef
17.
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131–138PubMedCrossRef
18.
Unger RH, Orci L (2001) Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 15:312–321PubMedCrossRef
19.
Blanc MC, Moinard C, Béziel A, Darquy S, Cynober L, De Bandt JP (2004) Arginine and glutamine availability and macrophage functions in the obese insulin-resistant Zucker rat. J Cell Physiol 202:153–159CrossRef
20.
Long K, Tayek JA (1999) Are gluconeogenic amino acids reduced in obese and non-obese type 2 diabetic patients (DM-2) compared to weight similar normal volunteers? Diabetes 48:A460–A461CrossRef
21.
Morris SM J (2000) Regulation of arginine availability and its impact on NO synthesis. In: Ignarro JL (ed) Nitric oxide: biology and pathobiology. Academic, San Diego, California, pp 187–197
22.
Fu WJ, Haynes TE, Kohli R et al (2005) Dietary l-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr 135:714–721PubMed
23.
Stumvoll M, Perriello G, Nurjhan N et al (1996) Glutamine and alanine metabolism in NIDDM. Diabetes 45:863–868PubMedCrossRef
24.
Brosnan JT, Man KC, Hall DE, Colbourne SA, Brosnan ME (1983) Interorgan metabolism of amino acids in streptozotocin-diabetic ketoacidotic rat. Am J Physiol 244:E151–E158PubMed
25.
Rodriguez T, Alvarez B, Busquets S, Carbo N, Lopez-Soriano FJ, Argiles JM (1997) The increased skeletal muscle protein turnover of the streptozotocin diabetic rat is associated with high concentrations of branched-chain amino acids. Biochem Mol Med 61:87–94PubMedCrossRef
26.
Nair KS, Short KR (2005) Hormonal and signaling role of branched-chain amino acids. J Nutr 135:1547S–1552SPubMed
27.
Manco M, Mingrone G (2005) Effects of weight loss and calorie restriction on carbohydrate metabolism. Curr Opin Clin Nutr Metab Care 8:431–439PubMedCrossRef
28.
Marchesini G, Bianchi GP, Vilstrup H, Capelli M, Zoli M, Pisi E (1991) Elimination of infused branched-chain amino-acids from plasma of patients with non-obese type 2 diabetes mellitus. Clin Nutr 10:105–113PubMedCrossRef
29.
Freyse EJ, Fischer U, Knospe S, Ford GC, Nair KS (2006) Differences in protein and energy metabolism following portal versus systemic administration of insulin in diabetic dogs. Diabetologia 49:543–551PubMedCrossRef
30.
Lasnier E, Coudray-Lucas C, Le Boucher J, Jardel A, Cynober L (1997) Ornithine a-ketoglutarate counteracts thymus involution and glutamine depletion in endotoxemic rats. Clin Nutr 77:197–200
31.
Breuille D, Voisin L, Contrepois M, Arnal M, Rose F, Obled C (1999) A sustained rat model for studying the long-lasting catabolic state of sepsis. Infect Immun 67:1079–1085PubMed
32.
Cooney RN, Kimball SR, Vary TC (1997) Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators. Shock 7:1–16PubMedCrossRef
33.
34.
Abumrad N, Barbul A (2003) The use of arginine in clinical practice. In: Cynober L (ed.) Metabolic and therapeutics aspects of amino acids in clinical nutrition. CRC, Boca Raton, Florida, pp 355–373
35.
Long CL, Birkhahn RH, Geiger JW, Betts JE, Schiller WR, Blakemore WS (1981) Urinary excretion of 3-methylhistidine: an assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis, and skeletal trauma. Metabolism 30:765–776PubMedCrossRef
36.
Minet-Quinard R, Moinard C, Walrand S et al (2000) Induction of a catabolic state in rats by dexamethasone: dose or time dependency? JPEN J Parenter Enteral Nutr 24:30–36PubMedCrossRef
37.
Mills CD (2001) Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. Crit Rev Immunol 21:399–426PubMed
38.
Austgen TR, Chakrabarti R, Chen MK, Souba WW (1992) Adaptive regulation in skeletal muscle glutamine metabolism in endotoxin-treated rats. J Trauma 32:600–606PubMedCrossRef
39.
Parry-Billings M, Leighton B, Dimitriadis G, de Vasconcelos PR, Newsholme EA (1989) Skeletal muscle glutamine metabolism during sepsis in the rat. Int J Biochem 21:419–423PubMedCrossRef
40.
Darmaun D (1999) Role of nutrients in the regulation of in vivo protein metabolism in humans. Acta Paediatr Suppl 88:92–94PubMedCrossRef
41.
Jeevanandam M, Ramias L, Schiller WR (1991) Altered plasma free amino acid levels in obese traumatized man. Metabolism 40:385–390PubMedCrossRef
42.
Jeevanandam M, Young DH, Schiller WR (1991) Obesity and the metabolic response to severe multiple trauma in man. J Clin Invest 87:262–269PubMedCrossRef
43.
Forbes GB, Drenick EJ (1979) Loss of body nitrogen on fasting. Am J Clin Nutr 32:1570–1574PubMed
44.
Leiter LA, Marliss EB (1982) Survival during fasting may depend on fat as well as protein stores. JAMA 248:2306–2307PubMedCrossRef
45.
Elia M, Stubbs RJ, Henry CJ (1999) Differences in fat, carbohydrate, and protein metabolism between lean and obese subjects undergoing total starvation. Obes Res 7:597–604PubMed
46.
Tessari P, Nissen SL, Miles JM, Haymond MW (1986) Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest 77:575–581PubMedCrossRef
47.
Beaufrere B, Chassard D, Broussole C, Riou JP, Beylot M (1992) Effects of d-beta-hydroxy-butyrate, long and medium chain triglycerides on leucine metabolism in man. Am J Physiol 262:E268–E274PubMed
Metadaten
Titel
The equivocal metabolic response to endotoxaemia in type 2 diabetic and obese ZDF rats
verfasst von
L. Belabed
G. Senon
M.-C. Blanc
A. Paillard
L. Cynober
S. Darquy
Publikationsdatum
01.06.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 6/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0233-4

Weitere Artikel der Ausgabe 6/2006

Diabetologia 6/2006 Zur Ausgabe

Article

Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone

Article

Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes

Article

Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria

Commentary

Digami too?

Article

Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines

For Debate

Anaemia in diabetes: is there a rationale to TREAT?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise